Enhanced Safety

STS uses PRT to ensure patient safety

illuminator enhanced safety

Secure Transfusion Services (STS) is the only commercial blood-collection group that makes 100% use of pathogen-reduction technology (PRT), a system approved by the US Food and Drug Administration (FDA) that minimizes the risk of bacterial and viral contamination in platelet collections.

Our approach eliminates the need for bacterial culture and gamma irradiation and provides specific infectious disease tests and potential protection from emerging pathogens. These vital steps help ensure that STS is a trusted, reliable, and safe source of platelets for hospitals to remain FDA-compliant and deliver lifesaving platelets to the patients they treat.

Read the data that show that PRT reduces pathogens in blood transfusions.

Additional Reading


Providing enhanced availability and reliability of apheresis platelets from a diverse, younger donor population.


Reducing supply chain interruptions to eliminate the impact to patient care


Expanding our national footprint for fast, on-demand deliveries


Building on a successful and proven path to platelet donations
Scroll to Top

Federal mandates may constrain platelet availability even more4,9

The safety of platelet transfusions is critical, and recent US Food and Drug Administration (FDA) mandates on bacterial risk mitigation require platelet collections to undergo proactive safety protocols, such as large volume delayed sampling or pathogen reduction. Platelet volume loss due to methods such as these may further erode the platelet supply.4,9

Secure Transfusion Services Icon